Episode 118 - Declan Doogan - CEO & Executive Chairman of Causeway Therapeutics  episode artwork

EPISODE · Feb 12, 2026 · 29 MIN

Episode 118 - Declan Doogan - CEO & Executive Chairman of Causeway Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

We were delighted to welcome Declan Doogan, CEO of Causeway Therapeutics, onto The BioHub! Declan is a highly respected leader in the biopharmaceutical industry, with decades of experience spanning drug development, clinical research, and executive leadership at some of the world’s leading pharmaceutical companies.Throughout his career, he has played a pivotal role in advancing innovative therapies from early discovery through to global commercialization. At Causeway Therapeutics, he is leading the charge in developing breakthrough treatments aimed at addressing serious and underserved medical needs.In this we discuss:Entrepreneurship and building a biotech having spent decades in PharmaCauseway's recent encouraging clinic results and what makes there approach different to what's out there alreadyHow Causeway are thinking about the pipeline and upcoming milestones

Episode metadata supplied by the publisher feed · Published Feb 12, 2026

Embed this episode

Ready to play

Episode 118 - Declan Doogan - CEO & Executive Chairman of Causeway Therapeutics

0:00 29:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 29 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on February 12, 2026.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!